Göteborg, Vastra Gotaland, Sweden In 1994 was created Innovations Kapital, which is appeared as VC. The leading representative office of defined VC is situated in the Gu00f6teborg. The company was established in Europe in Sweden.
The top amount of exits for fund were in 2007. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2006. Deals in the range of 5 - 10 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 6 percentage points more often commits exit comparing to other organizations. Opposing the other organizations, this Innovations Kapital works on 8 percentage points more the average amount of lead investments.
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Innovations Kapital, startups are often financed by Tesi, Teknoinvest, TVM Capital. The meaningful sponsors for the fund in investment in the same round are Teknoinvest, TVM Capital, Northzone. In the next rounds fund is usually obtained by Teknoinvest, Industrifonden, HealthCap.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Sweden. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Health Care. Among the most popular portfolio startups of the fund, we may highlight Novavax AB, Ludesi, Syntensia. The fund has specific favorite in a number of founders of portfolio startups.
This organization was formed by Staffan Ingeborn. The overall number of key employees were 2.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Action Pharma | $6M | 16 Jul 2010 | Central Denmark Region | ||
| $5M | 31 Jan 2010 | Oslo | |||
| $5M | 27 Nov 2007 | San Jose, California, United States | |||
| $7M | 31 Aug 2007 | Stockholm County | |||
Hymite | $11M | 11 Jan 2007 | Denmark, Capital Region of Denmark, Denmark | ||
Action Pharma | $6M | 27 Oct 2006 | Aarhus, Central Denmark Region, Denmark | ||
Resistentia Pharmaceuticals | $14M | 26 Sep 2006 | Uppsala, Uppsala County, Sweden | ||
Dolthera GmbH | $17M | 12 Aug 2005 | Bavaria | ||
NordNav Technologies | 09 Jun 2005 | Stockholm, Stockholm County, Sweden |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Action Pharma | $6M | 16 Jul 2010 | Central Denmark Region | ||
| $5M | 31 Jan 2010 | Oslo | |||
| $5M | 27 Nov 2007 | San Jose, California, United States | |||
| $7M | 31 Aug 2007 | Stockholm County | |||
Hymite | $11M | 11 Jan 2007 | Denmark, Capital Region of Denmark, Denmark | ||
Action Pharma | $6M | 27 Oct 2006 | Aarhus, Central Denmark Region, Denmark | ||
Resistentia Pharmaceuticals | $14M | 26 Sep 2006 | Uppsala, Uppsala County, Sweden | ||
Dolthera GmbH | $17M | 12 Aug 2005 | Bavaria | ||
NordNav Technologies | 09 Jun 2005 | Stockholm, Stockholm County, Sweden |
